AstraZeneca AgreementCommitment Form • November 18th, 2011 • Delaware
Contract Type FiledNovember 18th, 2011 JurisdictionThis Commitment Form (“Commitment Form”) is made by and between the undersigned entity, in its capacity as an Eligible Member, for the benefit of AstraZeneca LP (“AstraZeneca”), a Delaware limited partnership, as of the Effective Date (as hereinafter defined). This Commitment Form sets forth certain terms and conditions governing the Committed Pricing Options offered by AstraZeneca for Eligible Members under the current agreement between Minnesota Multistate Contracting Alliance for Pharmacy (“GPO”) and AstraZeneca (the “Agreement”) and the NEXIUM I.V. for Injection (hereinafter referred to as "NEXIUM I.V.") Product Schedule thereto (the “Product Schedule”) with respect to NEXIUM I.V. All capitalized terms not defined in this Commitment Form shall have the meaning set forth in the Product Schedule and/or the Agreement.